Daré Bioscience, Inc.
Income Statement
| Line Item | FY2012 |
|---|---|
| Revenue | $625.0K |
| Cost of Revenue | — |
| Gross Profit | — |
| Gross Margin | — |
| Operating Expenses | |
| Research & Development | $15.8M |
| SG&A Expense | $6.4M |
| Operating Income | — |
| Operating Margin | — |
| Interest Expense | $567.0K |
| Pretax Income | — |
| Income Tax Expense | — |
| Net Income | $-22.1M |
| Net Margin | -3,536.2% |
| EPS (Basic) | $-4.55 |
| EPS (Diluted) | $-4.55 |
| Shares Outstanding (Basic) | — |
| Shares Outstanding (Diluted) | — |
| Dividends Per Share | — |